Purchase Order HT001415P0721
Award Date
3/31/15
Potential Completion Date
12/31/15
Potential Value
$87K
Federal Agency
Defense Health Agency
Awardee
Pharmalucence, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order contract awarded by the Department of Defense Medical Command (MEDCOM) to Pharmalucence, Inc., a specialty pharmaceutical company, for the delivery of sulfur colloid kits. The contract has a ceiling value of $90,265.00 and a period of performance ending on September 30, 2016. Pharmalucence, Inc. has been awarded multiple federal contracts by the Department of Defense and its Defense Health Agency (DHA) component to supply radiopharmaceuticals and related...
This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Pharmalucence, Inc. for the supply of radiopharmaceuticals and related products. The contract has a ceiling value of $75,000.00 and a period of performance through September 30, 2024. Pharmalucence, Inc. is a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and supplies. The DHA, a component of the Department of...
This is a firm fixed-price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc. for the supply of various radiopharmaceuticals. The $100,000.00 contract has an ultimate completion date of September 30, 2025 and does not have a set-aside designation. Pharmalucence, Inc. is a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and...
This is a firm fixed-price purchase order awarded by the Department of the Army Medical Command to Pharmalucence, Inc., a for-profit manufacturer of pharmaceutical goods and medical supplies, for the delivery of radiopharmaceutical supplies, specifically sulfur colloid. The contract has a potential value of $162,030 and a period of performance ending on September 30, 2018. This award does not have a set-aside designation. Pharmalucence is an international, integrated, specialty pharmaceutical...
This contract was awarded by the Defense Health Agency (DHA) to Pharmalucence, Inc., a specialty pharmaceutical manufacturer, to provide radiopharmaceuticals and supplies. The contract is a firm fixed price blanket purchase agreement (BPA) call with a potential value of $25,000.00 and a completion date of September 30, 2023. The products will be delivered to facilities in El Paso, Texas to support nuclear medicine diagnostic services for the Military Health System's 9.5 million beneficiaries....
This federal contract award, valued at $250,000.00, was issued by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and radiopharmaceutical products. The contract covers the provision of various radiopharmaceuticals, with a period of performance through September 30, 2024. This award is part of a larger Blanket Purchase Agreement (BPA) that Lantheus Medical Imaging holds with the DHA, valued at $6.5 million and...
This is a $375,785.71 fixed-price with economic price adjustment purchase order contract awarded to Lantheus Medical Imaging, Inc. by the Defense Health Agency (DHA) for the procurement of radiopharmaceutical diagnostic products. The contract is set aside for small businesses and has an ultimate completion date of December 31, 2014. Lantheus Medical Imaging, a for-profit manufacturer of diagnostic medical imaging agents and products, is the prime contractor. The contract is part of a larger...
This contract award to Lantheus Medical Imaging, Inc. is a Blanket Purchase Agreement (BPA) call from the Defense Health Agency (DHA) for the delivery of radiopharmaceuticals. The contract has a ceiling value of $15,000.00 and a completion date of September 30, 2024. It is a firm fixed-price contract for the provision of critical nuclear medicine supplies and diagnostic imaging agents, primarily used in medical imaging procedures at military treatment facilities, VA medical centers, and other...
This is a federal contract award to Sun Pharmaceutical Industries, Inc., a for-profit manufacturer of pharmaceutical and radiopharmaceutical products, by the Defense Health Agency. The contract is for the provision of radiopharmaceuticals, with a ceiling value of $21,839.00 and a firm fixed-price pricing type. The contract has an ultimate completion date of September 30, 2025. Sun Pharmaceutical Industries, Inc. holds a significant Federal Supply Schedule contract with the Defense Health...
This federal contract award is for the provision of various radiopharmaceuticals to the Defense Health Agency (DHA) and U.S. Army Medical Command. The prime contractor is Curium US LLC, a foreign-owned, for-profit manufacturer of nuclear medicine products. The contract was awarded on October 1, 2023 as a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type and a total ceiling value of $100,000.00. It has an ultimate completion date of September 30, 2024. The contract...